Organigram Global Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
6.1
Neutral
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
OGI
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ low return on equity (5%).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
0 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
OGI
PFE
12.9×
Trailing P/E
19.4×
59.2×
Forward P/E
9.4×
6.5%
Profit Margin
12.4%
35.6%
Gross Margin
75.8%
4.6%
ROE
8.9%
48.7%
Revenue Growth
-1.2%
—
Earnings Growth
—
1.87
Beta
0.39
—
Price / Book
—
$200M
Market Cap
$149.8B
$1 – $2
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →